Clinical Trial Update: Safety and Pharmacokinetic Profile of CKD-581 [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and pharmacokinetic profile of CKD-581 in patients with lymphoma and multiple myeloma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• CKD-581

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Lymphoma, Multiple Myeloma | Phase 1 | Status: COMPLETED